[ad_1]
WASHINGTON – Two key federal health officials present new branch of the National Institutes of Health that would undertake higher risk research than the rest of the agency, with the aim of “transforming important areas of medicine and health “.
The new vision, from Biden science adviser Eric Lander and NIH director Francis Collins, gives new details to an initiative President Biden has touted as a new research agency to “end cancer like we know him â€. Their plan would push the new agency to focus on much broader goals, like inventing smartwatches that continuously monitor blood pressure, developing vaccines that can be designed and approved in 100 days, and finding new techniques to track impact. of Alzheimer’s disease on the brain. . ARPA-H will also focus on eliminating health disparities, they said.
Unlock this article by subscribing to STAT + and enjoy your first 30 days free!
TO START
What is that?
STAT + is STAT’s premium subscription service for in-depth coverage and analysis of biotechnology, pharmaceuticals, policy and life sciences. Our award-winning team covers news from Wall Street, political developments in Washington, early scientific breakthroughs and clinical trial results, as well as healthcare disruptions in Silicon Valley and beyond.
What is included?
- Daily reporting and analysis
- Industry’s most comprehensive coverage from a powerful team of journalists
- Newsletters reserved for subscribers
- Daily newsletters to keep you informed of the most important industry news of the day
- STAT + conversations
- Weekly opportunities to engage with our journalists and leading industry experts in live video chats
- Exclusive industry events
- Premium access to subscriber-only networking events nationwide
- The best reporters in the industry
- The most reliable and most connected newsroom in healthcare
- And much more
- Exclusive interviews with industry leaders, profiles and premium tools, like our CRISPR Trackr.
[ad_2]
